JUN TERUYA to Heparin
This is a "connection" page, showing publications JUN TERUYA has written about Heparin.
Connection Strength
2.831
-
The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay. Arch Pathol Lab Med. 2014 Nov; 138(11):1503-6.
Score: 0.420
-
Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*. Pediatr Crit Care Med. 2014 Feb; 15(2):178-9.
Score: 0.399
-
Complications of anticoagulation. Dis Mon. 2012 Aug; 58(8):440-7.
Score: 0.359
-
Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol. 2010 Dec; 134(6):950-4.
Score: 0.320
-
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation. Semin Thromb Hemost. 2024 Feb; 50(1):81-90.
Score: 0.186
-
Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study. Pediatr Crit Care Med. 2022 10 01; 23(10):e465-e475.
Score: 0.178
-
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods. Int J Lab Hematol. 2022 Jun; 44(3):589-594.
Score: 0.172
-
C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII. Int J Lab Hematol. 2021 Feb; 43(1):139-142.
Score: 0.157
-
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation. Semin Thromb Hemost. 2020 Feb; 46(1):62-72.
Score: 0.150
-
Antithrombin Population Pharmacokinetics in Pediatric Ventricular Assist Device Patients. Pediatr Crit Care Med. 2019 12; 20(12):1157-1163.
Score: 0.149
-
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014 Jun; 15(5):e198-205.
Score: 0.102
-
Practice guidelines for reversal of new and old anticoagulants. Dis Mon. 2012 Aug; 58(8):448-61.
Score: 0.090
-
Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory. Ann Pharmacother. 2011 Jul; 45(7-8):876-80.
Score: 0.084
-
Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
Score: 0.032
-
Artifact hyperfibrinolysis in thromboelastography with the use of a heparinase cup. Arch Pathol Lab Med. 2010 Dec; 134(12):1736.
Score: 0.020
-
Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost. 2007 Apr; 33(3):250-8.
Score: 0.016